<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26195909</article-id><article-id pub-id-type="pmc">4492031</article-id><article-id pub-id-type="publisher-id">AYU-35-438</article-id><article-id pub-id-type="doi">10.4103/0974-8520.159020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacological Study</subject></subj-group></article-categories><title-group><article-title>Bioavailability study of calcium sandoz-250 by atomic absorption spectroscopy in albino rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Bimalkumar N.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Krishnaveni</surname><given-names>N.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Jivani</surname><given-names>Nurrrudin P.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Khodakiya</surname><given-names>Akruti S.</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Khodakiya</surname><given-names>Moorti S.</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Parida</surname><given-names>Saswat K.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Pharmaceutical Analysis, C.U. Shah College of Pharmacy and Research, Wadhwan, Gujarat, India</aff><aff id="aff2"><label>1</label>Department of Pharmaceutical Analysis, J.S.S. College of Pharmacy, Ooty, Tamil Nadu, India</aff><aff id="aff3"><label>2</label>Department of Pharmaceutics, C.U. Shah College of Pharmacy and Research, Wadhwan, Gujarat, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Mr. Bimalkumar N. Patel, 68, Kunta Park Society, Near Taramani Township, New 80 Feet Road, Wadhwan City, Surendranagar - 363 035, Gujarat, India. E-mail: <email xlink:href="bimal.analysis@gmail.com">bimal.analysis@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2014</year></pub-date><volume>35</volume><issue>4</issue><fpage>438</fpage><lpage>441</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Calcium sandoz-250 is an Ayurvedic calcium supplement, containing <italic>Khatika Churna</italic>. Bioavailability study of the formulation is essential for estimation of peak plasma concentration (<italic>C</italic><sub>max</sub>), time to <italic>C</italic><sub>max</sub> and rate of absorption.</p></sec><sec id="st2"><title>Aim:</title><p>To evaluate the absorption parameters of calcium sandoz-250 in albino rats by atomic absorption spectroscopic (AAS) method.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>Study was carried out as a single dose, open-label, randomized study. Estimation of calcium was carried out by AAS, after validating the method for a few parameters for the estimation. Pharmacokinetic parameters such as <italic>C</italic><sub>max</sub>, time to peak concentration (<italic>T</italic><sub>max</sub>), area under the plasma concentration - time curve were calculated for calcium on administration of calcium sandoz-250.</p></sec><sec id="st4"><title>Results:</title><p>Linearity curve was plotted for 0.5-2.5 ppm, given <italic>R</italic><sup>2</sup> value 0.9975. The <italic>C</italic><sub>max</sub>, i.e. <italic>C</italic><sub>max</sub> after administration of calcium sandoz-250 was 0.793 mg/ml at 90 min (<italic>T</italic><sub>max</sub>). Measurable calcium-blood levels were noticed in all subjects up to 3.0 h after administration of calcium sandoz-250.</p></sec><sec id="st5"><title>Conclusion:</title><p>Calcium sandoz-250, consisting of <italic>Khatika Churna</italic>, increases the blood calcium level in albino rats.</p></sec></abstract><kwd-group><kwd>Ayurvedic formulation</kwd><kwd>bioavailability study</kwd><kwd>calcium sandoz-250</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Calcium (Ca) is one of the most important extracellular cation.[<xref rid="ref1" ref-type="bibr">1</xref>] Approximately, 99% of the body's Ca is stored in the bones and teeth.[<xref rid="ref2" ref-type="bibr">2</xref>] Apart from supporting the skeletal integrity, Ca plays an important role in blood clots, muscular contractility and nervous excitability.[<xref rid="ref3" ref-type="bibr">3</xref>] Although serum Ca levels can be maintained in the normal range by bone resorption, dietary intake is the only source by which the body can replenish stores of Ca in bone. Ca is absorbed almost exclusively within the duodenum, jejunum and ileum. Each of these intestinal segments has a high absorptive capacity for Ca, with their relative Ca absorption being dependent on the length of each respective intestinal segment and the transit time of the food bolus. The calcium intake is critical during the 1<sup>st</sup> year of life for the anatomical structure.[<xref rid="ref4" ref-type="bibr">4</xref>] Prospective studies demonstrated that the biggest increase of the bone mass occurs principally during the age of puberty.[<xref rid="ref5" ref-type="bibr">5</xref>] An inadequate calcium intake during the growth period may cause a failure to reach the increase in bone mass. This situation produces different bone and illnesses such as osteopenia, osteoporosis, decreased skeletal integrity, increasing the fracture risk in later life.[<xref rid="ref6" ref-type="bibr">6</xref>] Some of the researchers have reported that the increase in calcium intake attenuates the bone mass loss during the age of menopause.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] It appears that all the calcium in food or other source is available for absorption, but the absolute amount is determined by physiological factors such as efficiency of absorption, calcium need, vitamin D, age and hormonal status, etc.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>]</p><p>Calcium sandoz is a popular brand of calcium supplement, used widely throughout the world; mainly by children and women. Calcium sandoz contains calcium carbonate as the main ingredient.[<xref rid="ref12" ref-type="bibr">12</xref>] However, calcium sandoz-250 contains <italic>Khatika Churna</italic>, as it is an ayurvedic preparation and it is claimed to have 250 mg calcium equivalent in each chewable tablet.[<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref>] Bioavailability of calcium from calcium sandoz-250 was studied in animal model as a preclinical trial. There have been no studies in humans about the bioavailability of calcium from calcium sandoz-250. As calcium sandoz-250 is an Ayurvedic formulation, the absorption might shows variations from the data of the allopathic formulation of calcium supplements or food.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref>]</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Animals</title><p>Adult male wistar albino rats (<italic>n</italic> = 12) weighing 120-150 g were procured from central animal facility and housed in cages under standard laboratory conditions (10 h dark/14 h light, temperature 20-25&#x000b0;C, relative humidity 65%) for 7 days.</p></sec><sec id="sec2-2"><title>Reagents and chemicals</title><p>Ultra-pure water, metal standard solutions of calcium (sigma Aldrich) were prepared by appropriate dilutions of 1000 mg/L stock solutions.</p></sec><sec id="sec2-3"><title>Instrumentation</title><p>Shimadzu model AA 6300 flame atomic absorption spectrometer (AAS) (Tokyo&#x02013;Japan) equipped with a deuterium background corrector and a hydride vapor generator for analysis of arsenic. Hollow cathode lamps of specific metals were used as a radiation source.</p></sec><sec id="sec2-4"><title>Study design</title><p>The study was randomized single dose study, included two equal groups of animals (<italic>n</italic> = 6 in each). The protocol was duly approved by the Institutional animal ethics committee (No. JSSCP/IAEC/M.PHARM/PHARM.ANALYSIS/05/2009-2010).</p></sec><sec id="sec2-5"><title>Drug assignment</title><p>Two equal groups were made from all albino rats. First group received calcium sandoz-250 (dose was calculated according to the body weight of the animal) and the second group kept as control.</p><p>Single dose of calcium sandoz was given to each of the six rats after an overnight fasting. Blood sample was collected from the tail vein of rats after 0.0, 0.15, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 12.0, 24.0 and 36.0 hrs of drug administration. The amount of calcium sandoz was measured by a suitable flame AAS method.</p></sec><sec id="sec2-6"><title>Preparation of standard calcium solution</title><p>Standard calcium solutions were prepared from 1000 mg/L stock solution. A serial dilution containing 0.5, 1.0, 1.5, 2.0 and 2.5 ppm of calcium were prepared and used as working standards.</p><p>These solutions were then subjected to analysis by flame AAS under the following instrumental conditions:</p><p><inline-graphic xlink:href="AYU-35-438-g001.jpg"/></p><p>The absorbances of the standard solutions were recorded and the calibration curve was plotted by taking concentration in <italic>X</italic>-axis and absorbance in <italic>Y</italic>-axis.</p></sec><sec id="sec2-7"><title>Estimation of calcium in plasma samples</title><sec id="sec3-1"><title>Optimization of the extraction procedure</title><p>For the estimation of calcium in plasma, animal plasma was spiked with standard calcium solution. To precipitate the plasma protein as they may coagulate on heating, the following methods were tried:</p><p>
<list list-type="bullet"><list-item><p>Precipitation of plasma proteins with perchloric acid (10%)</p></list-item><list-item><p>Precipitation of plasma proteins with trichloroacetic acid (10% and 20%)</p></list-item><list-item><p>Precipitation of plasma proteins with nitric acid</p></list-item><list-item><p>Dilution of the plasma samples 50 fold with deionized water.</p></list-item></list>
</p></sec><sec id="sec3-2"><title>Methods</title><p>A total volume of 0.2 ml plasma was taken, to this appropriate amount of standard calcium solution (2.0 ppm) and 0.2 ml of precipitating agents (perchloric acid, trichloroacetic acid and nitric acid) were added. The volume was made to 1 ml with deionized water. The resulting solutions were centrifuged at 4000 rpm for 5 min and supernatant was taken and diluted to 10 ml with deionized water.</p><p>However in all cases recovery were found to be less than 50%, so finally direct estimation was done by diluting the plasma by 50 fold using deionized water. The resulting samples on analysis gave good recovery (above 95%).</p><p>Calibration curve was plotted for the concentration range of 0.5 ppm to 2.5 ppm in plasma and the method was validated for following parameters</p><p>
<list list-type="bullet"><list-item><p>Linearity</p></list-item><list-item><p>Range</p></list-item><list-item><p>Precision</p></list-item><list-item><p>Accuracy.</p></list-item></list>
</p><p>The samples obtained from the animal study were analyzed by the same method.</p></sec></sec></sec><sec id="sec1-3"><title>Results and Discussion</title><p>Linearity curve was plotted for the solutions of calcium solutions ranging from 0.5 &#x003bc;g/ml to 2.5 &#x003bc;g/ml [<xref ref-type="table" rid="T1">Table 1</xref>], giving <italic>R</italic><sup>2</sup> value 0.9975 and slope 0.0163 [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Linearity range of calcium standard solution by AAS</p></caption><graphic xlink:href="AYU-35-438-g002"/></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Linearity plot of calcium standard solution by atomic absorption spectroscopic</p></caption><graphic xlink:href="AYU-35-438-g003"/></fig><p>Extraction method was optimized for extraction of calcium from the plasma. Recovery with protein precipitation was less than 50% for almost all precipitating agent, while direct determination of calcium with 50 fold dilution gave 98.5% recovery [<xref ref-type="table" rid="T2">Table 2</xref>]. Recovery was studied for all the concentration of the calibration curve giving the result between 94.28% and 107.14% [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Optimization of method</p></caption><graphic xlink:href="AYU-35-438-g004"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Linearity and recovery study</p></caption><graphic xlink:href="AYU-35-438-g005"/></table-wrap><p>Calibration curve was plotted for the plasma samples spiked with the known amount of calcium, with <italic>R</italic><sup>2</sup> value 0.995, slope 0.014 and intercept 0.001 [<xref ref-type="table" rid="T4">Table 4</xref>, <xref ref-type="fig" rid="F2">Figure 2</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Calibration curve of calcium in plasma by AAS</p></caption><graphic xlink:href="AYU-35-438-g006"/></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Calibration curve of calcium in atomic absorption spectroscopic</p></caption><graphic xlink:href="AYU-35-438-g007"/></fig><p>Plasma samples collected from the animals at different intervals were analyzed for the calcium content after blank was introduced, detectable amount measured after 15 min of administration. Pharmacokinetic parameters such as peak plasma concentration (<italic>C</italic><sub>max</sub>), Time to peak concentration (<italic>T</italic><sub>max</sub>), Area under the plasma concentration-time curve (AUC<sub>0-t</sub> and AUC<sub>0-&#x0221e;</sub>) were calculated for calcium on administration of calcium sandoz-250 [<xref ref-type="table" rid="T5">Table 5</xref>].</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Mean plasma concentration of calcium from animal (administered calcium sandoz-250)</p></caption><graphic xlink:href="AYU-35-438-g008"/></table-wrap><p><xref ref-type="fig" rid="F3">Figure 3</xref> shows bioavailability curve of the calcium after oral administration of calcium sandoz-250. A summary of different pharmacokinetic parameters was depicted in <xref ref-type="table" rid="T6">Table 6</xref>.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Mean plasma concentration of calcium from animals (administered calcium sandoz-250)</p></caption><graphic xlink:href="AYU-35-438-g009"/></fig><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Pharmacokinetic parameters</p></caption><graphic xlink:href="AYU-35-438-g010"/></table-wrap><sec id="sec2-8"><title>Pharmacokinetics data of calcium sandoz-250 obtained from bioavailability study</title><p>
<list list-type="bullet"><list-item><p>Pharmacokinetic parameters such as <italic>C</italic><sub>max</sub>, <italic>T</italic><sub>max</sub>, AUC<sub>0-t</sub> and AUC<sub>0-&#x0221e;</sub> were calculated for calcium on administration of calcium sandoz-250</p></list-item><list-item><p>Measurable calcium-blood levels were noticed in all subjects up to 3.0 h after administration of calcium sandoz-250</p></list-item><list-item><p>The <italic>C</italic><sub>max</sub>, i.e. <italic>C</italic><sub>max</sub> after administration of calcium sandoz-250 was 0.793 &#x003bc;g/ml at 90 min (<italic>T</italic><sub>max</sub>)</p></list-item><list-item><p>AUC<sub>0-t</sub> and AUC<sub>0-&#x0221e;</sub> were found to be 79.28571 and 80.82454 respectively</p></list-item><list-item><p><italic>K</italic><sub>eli</sub> and half-life for the calcium sandoz-250 (Ayurvedic formulation) were found to be 0.030172 and 22.97 min respectively.</p></list-item></list>
</p></sec></sec><sec sec-type="conclusion" id="sec1-4"><title>Conclusion</title><p>On the basis of the results obtained from the study, conclusion can be drawn that calcium Sandoz-250, consisting of <italic>Khatika Churna</italic>, increases the blood calcium level in albino rats. Hence, further investigation should be carried out to evaluate the effect of calcium sandoz-250 on human blood calcium level.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Brunton</surname><given-names>LL</given-names></name></person-group><article-title>Goodman and Gilman's The Pharmacological Basis of Therapeutics</article-title><year>1990</year><edition>8th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Pergamon Press</publisher-name></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><article-title>Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D</article-title><year>2010</year><date-in-citation>Last accessed on 2013 Aug 12</date-in-citation><publisher-loc>Washington</publisher-loc><publisher-name>National Academy Press</publisher-name><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.iom.edu">http://www.iom.edu</uri></comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levenson</surname><given-names>DI</given-names></name><name><surname>Bockman</surname><given-names>RS</given-names></name></person-group><article-title>A review of calcium preparations</article-title><source>Nutr Rev</source><year>1994</year><volume>52</volume><fpage>221</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">8090373</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JJ</given-names></name></person-group><article-title>Calcium, phosphorus and human bone development</article-title><source>J Nutr</source><year>1996</year><volume>126</volume><fpage>1153S</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8642449</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>CC</given-names><suffix>Jr</suffix></name><name><surname>Miller</surname><given-names>JZ</given-names></name><name><surname>Slemenda</surname><given-names>CW</given-names></name><name><surname>Reister</surname><given-names>TK</given-names></name><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Christian</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Calcium supplementation and increases in bone mineral density in children</article-title><source>N Engl J Med</source><year>1992</year><volume>327</volume><fpage>82</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1603140</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matkovic</surname><given-names>V</given-names></name><name><surname>Fontana</surname><given-names>D</given-names></name><name><surname>Tominac</surname><given-names>C</given-names></name><name><surname>Goel</surname><given-names>P</given-names></name><name><surname>Chesnut</surname><given-names>CH</given-names><suffix>3rd</suffix></name></person-group><article-title>Factors that influence peak bone mass formation: A study of calcium balance and the inheritance of bone mass in adolescent females</article-title><source>Am J Clin Nutr</source><year>1990</year><volume>52</volume><fpage>878</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">2239765</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elders</surname><given-names>PJ</given-names></name><name><surname>Netelenbos</surname><given-names>JC</given-names></name><name><surname>Lips</surname><given-names>P</given-names></name><name><surname>Van Ginkel</surname><given-names>FC</given-names></name></person-group><article-title>Calcium supplementation reduces perimenopausal bone loss</article-title><source>J Bone Miner Res</source><year>1989</year><volume>4</volume><fpage>1128</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>RL</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Dick</surname><given-names>IM</given-names></name><name><surname>Price</surname><given-names>RI</given-names></name><name><surname>Webb</surname><given-names>PG</given-names></name><name><surname>Henderson</surname><given-names>NK</given-names></name><etal/></person-group><article-title>Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy</article-title><source>N Engl J Med</source><year>1991</year><volume>325</volume><fpage>1189</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">1922205</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recker</surname><given-names>RR</given-names></name><name><surname>Saville</surname><given-names>PD</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name></person-group><article-title>Effect of estrogens and calcium carbonate on bone loss in postmenopausal women</article-title><source>Ann Intern Med</source><year>1977</year><volume>87</volume><fpage>649</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">201203</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrissey</surname><given-names>PA</given-names></name><name><surname>Flynn</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kon</surname><given-names>SK</given-names></name></person-group><article-title>Bioavailability of minerals in milks</article-title><source>Milk and Milk Products in Human Nutrition. FAO Nutritional Studies, Woodhead Publishing</source><year>1972</year><fpage>27</fpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortensen</surname><given-names>L</given-names></name><name><surname>Charles</surname><given-names>P</given-names></name></person-group><article-title>Bioavailability of calcium supplements and the effect of Vitamin D: Comparisons between milk, calcium carbonate, and calcium carbonate plus vitamin D</article-title><source>Am J Clin Nutr</source><year>1996</year><volume>63</volume><fpage>354</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8602592</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="webpage"><date-in-citation>Last accessed on 2013 Aug 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.mims.com/India/drug/info/CALCIUM%20SANDOZ/CALCIUM%20SANDOZ%20chewable%20tab">http://www.mims.com/India/drug/info/CALCIUM%20SANDOZ/CALCIUM%20SANDOZ%20chewable%20tab</uri></comment></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Mengshetti</surname><given-names>P</given-names></name></person-group><article-title>Novartis says Khatika Churna-Calcium Sandoz@250 contains no calcium</article-title><year>2009</year><month>4</month><day>14</day><date-in-citation>Last accessed on 2013 Aug 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://pharmaweb4u.blogspot.in/2009/04/novartis-says-khatika-churna-calcium.html">http://pharmaweb4u.blogspot.in/2009/04/novartis-says-khatika-churna-calcium.html</uri></comment></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="webpage"><article-title>India Business Insight</article-title><year>2009</year><month>4</month><day>09</day><date-in-citation>Last accessed on 2013 Aug 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.accessmylibrary.com/article-1G1-200709783/trade-objects-novartis-sale.html">http://www.accessmylibrary.com/article-1G1-200709783/trade-objects-novartis-sale.html</uri></comment></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>MC</given-names></name><name><surname>Gallaher</surname><given-names>BW</given-names></name><name><surname>Schollum</surname><given-names>LM</given-names></name></person-group><article-title>Bioavailability of calcium is equivalent from milk fortified with either calcium carbonate or milk calcium in growing male rats</article-title><source>Nutr Res</source><year>2003</year><volume>23</volume><fpage>1229</fpage><lpage>37</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarabia</surname><given-names>MI</given-names></name></person-group><article-title>Bioavailability, biodistiubution and toxicity of biocaltm, a new calcium source, comparative studies in rats</article-title><source>Nutr Res</source><year>1999</year><volume>19</volume><fpage>1223</fpage><lpage>31</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranhotra</surname><given-names>GS</given-names></name><name><surname>Gelroth</surname><given-names>JA</given-names></name><name><surname>Leinen</surname><given-names>SD</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name></person-group><article-title>Bioavailability of calcium in a high calcium whey fraction</article-title><source>Nutr Res</source><year>1997</year><volume>17</volume><fpage>1660</fpage><lpage>70</lpage></element-citation></ref></ref-list></back></article>